REGISTERED
on 11 Oct 2022
Last Applicant/ Owned by
88 Sidney Street
Cambridge
MA
021394169
Serial Number
90768935 filed on 11th Jun 2021
Registration Number
6874040 registered on 11th Oct 2022
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
PYRUKYND
Pharmaceutical preparations, namely, for the activation of PKR (pyruvate kinase R), for the activation of PKM2 (pyruvate kinase isozyme M2), and for the prevention and treatment of blood disorders, pyruvate kinase deficiency (PKD), genetically defined diseases affecting red blood cells, hemolytic anemia
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical preparations, namely, for the activation of PKR (pyruvate kinase R), for the activation of PKM2 (pyruvate kinase isozyme M2), and for the prevention and treatment of blood disorders, pyruvate kinase deficiency (PKD), genetically defined diseases affecting red blood cells, hemolytic anemia
First Use Date in General
25th Feb 2022
First Use Date in Commerce
25th Feb 2022
Mark Details
Serial Number
No 90768935
Mark Type
No Service/Collective Mark
Attorney Docket Number
No
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Design Code(s)
01.01.05 -
Stars with seven or more points
24.17.15 -
Check marks
26.17.12 -
Chevrons and angles
Legal History
| Status Date | Action Taken |
|---|---|
| 11th Oct 2022 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 11th Oct 2022 | REGISTERED-PRINCIPAL REGISTER |
| 03rd Sep 2022 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 02th Sep 2022 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 29th Aug 2022 | STATEMENT OF USE PROCESSING COMPLETE |
| 27th Aug 2022 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 21st Jun 2022 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 02th Jun 2022 | USE AMENDMENT FILED |
| 02th Jun 2022 | TEAS STATEMENT OF USE RECEIVED |
| 09th Feb 2022 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |